TaipeiAnd the September 28, 2022 /PRNewswire/ — Point Robotics MedTech Inc. (Point Robotics), a rising star in the field of orthopedics, received 510(k) approval from the U.S. Food and Drug Administration (FDA) for its minimally invasive surgical robot, the POINT™ Kinguide Robot-Assisted Surgical System, in August. This premarket notification distinguishes both Taiwan The world’s first FDA approved surgical robot and the world’s first ever portable parallel processor robot frame for orthopedic application.
An integrated surgical system that includes both image-guided mobility and manual drilling features, the “Kinguide Robotic-Assisted Surgical System” simplifies procedural tasks and greatly reduces the surgeon’s burden during spinal fusion operations, and its outstanding performance in precision, stability and reproducibility Robotic movement can improve outcomes surgery that was highly dependent on the experience of the surgeon. The main difference between Point Robotics and the other is its scalability to refer to more complex disc decompression surgery enabled by the unique parallel manipulator mechanism.
Point Robotics anticipates diving into the blue ocean market by meeting larger unmet clinical needs with next-generation products. Point Robotics is revolutionizing spine surgery by combining clinical knowledge gained from surgeons’ years of experience with cutting-edge technologies. Jackie Yang saidCo-founder of Translink Capital in Silicon Valley.
Point Robotics prepares for CE marking in Europe and certificate of registration in China To start global deployments and reach international markets. According to Frost & Sullivan, the global orthopedic surgical robots market size is expected to reach approximately 8 billion US dollars By 2030 at a compound annual growth rate of nearly 20%, indicating a promising market potential driven by the increasing demand for surgical robots in light of its clinical benefits and key technologies breakthrough. To ride the wave of strong market momentum, “It is our honor to make the global debut of this advanced robotics system starting with the largest surgical robotics market in the world – United State. We aim to enhance the availability and affordability of robotic adoption in spine surgery that today’s technology has not addressed to treat more patients with a variety of spinal conditions. Involvement of strategic partners and business models, such as joint ventures, licensing, strategic alliances, etc.
To further reveal potential needs in the markets, Point Robotics has conducted a month-long product demonstration for surgeons on the West Coast of the United States since August, and will launch the “Kinguide Robotic-Assisted Surgical System” at the following medical conferences: SMISS (9/29-10/1) , Las vigasBooths No. 107 & #109), Nas (10/12-10/14), Chicagobooth No. 5011) and EUROSPINE (10/19-10/21, Milan, booth #102). For more information visit https://www.pointroboticsinc.com
About Point Robotics MedTech Inc.
Point Robotics MedTech, a leader in minimally invasive surgery techniques, was founded in Taiwan In 2016. The company owns two main production lines: “Kinguide Robot-assisted Surgical System” and “Kinguide Agile Hybrid Navigation System. May 2020the company completed her chain-Fundraising from government funds, Taiwania Capital and Translink Capital. Point Robotics MedTech will continue to focus on the development and regulatory approvals for next-generation products to maintain its leading position in the high-end surgical robotics market.
SOURCE Point Robotics MedTech Inc.
#manual #spine #surgical #robot #Point #Robotics #MedTech #debut #worldwide #United #States